Mouse bone marrow micronucleus test results do not predict the germ cell mutagenicity of N-hydroxymethylacrylamide in the mouse dominant lethal assay.
N-Hydroxymethylacrylamide (NHMA), a mouse carcinogen inactive in the Salmonella assay and mouse micronucleus (MN) assay, was tested for reproductive effects in a mouse continuous breeding study. In that study, increased embryonic deaths were observed after 13 weeks exposure of parental animals to NHMA via drinking water (highest dose, 360 ppm); the results indicated the possible induction of chromosome damage in germ cells of treated males. An additional mouse MN test was conducted using a 31-day treatment period to better match the dosing regimen used in the breeding study; the results were negative. Additional studies were conducted to explore the germ cell activity of NHMA. A male mouse dominant lethal study was conducted using a single intraperitoneal injection of 150 mg/kg NHMA; the results were negative. A follow-up study was conducted using fractionated dosing, 50 mg/kg/day for 5 days; again, no increase in dominant lethal mutations was observed. NHMA (180-720 ppm) was then administered to male mice in drinking water for 13 weeks, during which three sets of matings occurred. Two weeks after mating, females were killed and the uterine contents were analyzed. Large, dose-related increases in dominant lethal mutations were observed with increasing length of exposure. The magnitude of the increases stabilized after 8 weeks of treatment. However, the frequency of micronucleated peripheral blood erythrocytes was not elevated in mice treated for 13 weeks with NHMA in drinking water. Thus, NHMA appears to be unique in inducing genetic damage in germ cells but not somatic cells of male mice.
Witt
Kristine L
KL
Information Sciences Division, Integrated Laboratory Systems, Inc., Research Triangle Park, North Carolina, USA.
Hughes
Lori A
LA
Burka
Leo T
LT
McFee
Alfred F
AF
Mathews
James M
JM
Black
Sherry L
SL
Bishop
Jack B
JB
D000178:Acrylamides / Q000008:administration & dosage / Q000633:toxicity* / Q000652:urine; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D002869:Chromosome Aberrations; D004912:Erythrocytes; D005260:Female; D005799:Genes, Dominant; D005804:Genes, Lethal; D005854:Germ Cells / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D015162:Micronucleus Tests; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D014867:Water
D000178:Acrylamides; D009153:Mutagens; D014867:Water; C066443:N-methylolacrylamide